CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers

Farma Darya

TEL AVIV, Israel and SEOUL, South Korea, April 12, 2022 /PRNewswire/ — CytoReason, a leading developer of computational disease models for efficient drug discovery and development, announced today the signing of a commercial partnership with Helixrus, a leading Korean company focused on biological big data and multi-omics. The partnership will […]

Partners Across Health Care, Academia and Patient Advocacy Launch the Digital Health for Equitable Health Alliance, a Unique Coalition to Address Disparities in Access to Healthcare using Digital Health Technology

Farma Darya

The Digital Health for Equitable Health Alliance brings together multi-sector stakeholders, leaders, and advocates to promote a more digitally inclusive and accessible society that will transform health delivery for underserved populations. WASHINGTON, May 19, 2022 /PRNewswire/ — Today, a unique coalition was launched that aims to address health disparities for […]

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse

Farma Darya

The Consortium jointly, through Aztiq II HoldCo, has completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo Róbert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the […]